Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Knowledge, attitudes, and practices related to meningitis in northern Ghana.

Hayden MH, Dalaba M, Awine T, Akweongo P, Nyaaba G, Anaseba D, Pelzman J, Hodgson A, Pandya R.

Am J Trop Med Hyg. 2013 Aug;89(2):265-70. doi: 10.4269/ajtmh.12-0515. Epub 2013 Jun 17.

2.

Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.

Noronha CP, Struchiner CJ, Halloran ME.

Int J Epidemiol. 1995 Oct;24(5):1050-7.

PMID:
8557439
3.

Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana.

Gagneux SP, Hodgson A, Smith TA, Wirth T, Ehrhard I, Morelli G, Genton B, Binka FN, Achtman M, Pluschke G.

J Infect Dis. 2002 Mar 1;185(5):618-26. Epub 2002 Feb 14.

PMID:
11865418
4.

Genetic diversification of Neisseria meningitidis during waves of colonization and disease in the meningitis belt of sub-Saharan Africa.

Leimkugel J, Forgor AA, Dangy JP, Pflüger V, Gagneux S, Hodgson A, Pluschke G.

Vaccine. 2007 Sep 3;25 Suppl 1:A18-23. Epub 2007 May 7.

PMID:
17531357
5.

Patterns of meningococcal infection in Sudan with emergence of Neisseria meningitidis serogroup W135.

Karsany MS, Elshayeb AA, Saeed ES, Elaagib R, Ibrahim SA, Elsamani E, Hussien K, Salih KM.

East Mediterr Health J. 2013 Oct;19(10):843-6.

PMID:
24313147
6.

Microheterogeneity of serogroup A (subgroup III) Neisseria meningitidis during an outbreak in northern Ghana.

Gagneux S, Hodgson A, Ehrhard I, Morelli G, Genton B, Smith T, Tanner M, Binka F, Achtman M, Pluschke G.

Trop Med Int Health. 2000 Apr;5(4):280-7.

7.

Risk factors for meningococcal meningitis in northern Ghana.

Hodgson A, Smith T, Gagneux S, Adjuik M, Pluschke G, Mensah NK, Binka F, Genton B.

Trans R Soc Trop Med Hyg. 2001 Sep-Oct;95(5):477-80.

PMID:
11706652
8.

Neisseria meningitidis serogroup A vaccines: an overview.

Vergnano S, Heath P.

Expert Rev Vaccines. 2003 Aug;2(4):571-82. Review.

PMID:
14711341
9.

Meningococcal meningitis in northern Ghana: epidemiology and control measures.

Belcher DW, Sherriff AC, Nimo KP, Chew GL, Richardson WD, Voros A, Feldman HA, Richardson WD, Feldman HA.

Am J Trop Med Hyg. 1977 Jul;26(4):748-55.

PMID:
889015
10.

Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity.

Mueller JE, Yaro S, Njanpop-Lafourcade BM, Drabo A, Idohou RS, Kroman SS, Sanou O, Diagbouga S, Traoré Y, Sangaré L, Borrow R, Gessner BD.

J Infect Dis. 2011 Dec 1;204(11):1787-95. doi: 10.1093/infdis/jir623. Epub 2011 Oct 12.

11.

Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso.

Vogel G.

Science. 2003 Mar 7;299(5612):1499-501. No abstract available.

PMID:
12624241
12.

Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.

Okoko BJ, Idoko OT, Adegbola RA.

Vaccine. 2009 Mar 23;27(14):2023-9. doi: 10.1016/j.vaccine.2008.11.092. Epub 2008 Dec 16. Review.

PMID:
19095025
13.

[Africa: towards the eradication of meningitis A?].

Nau JY.

Rev Med Suisse. 2011 Jun 22;7(300):1378-9. French. No abstract available.

PMID:
21815540
14.

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.

Marc LaForce F, Ravenscroft N, Djingarey M, Viviani S.

Vaccine. 2009 Jun 24;27 Suppl 2:B13-9. doi: 10.1016/j.vaccine.2009.04.062. Epub 2009 May 27. Review.

PMID:
19477559
15.

Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States.

Mandal S, Wu HM, MacNeil JR, Machesky K, Garcia J, Plikaytis BD, Quinn K, King L, Schmink SE, Wang X, Mayer LW, Clark TA, Gaskell JR, Messonnier NE, DiOrio M, Cohn AC.

Clin Infect Dis. 2013 Aug;57(3):344-8. doi: 10.1093/cid/cit243. Epub 2013 Apr 17.

PMID:
23595832
16.

Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000.

Djibo S, Nicolas P, Alonso JM, Djibo A, Couret D, Riou JY, Chippaux JP.

Trop Med Int Health. 2003 Dec;8(12):1118-23.

17.

Infectious disease. An ill wind, bringing meningitis.

Roberts L.

Science. 2008 Jun 27;320(5884):1710-5. doi: 10.1126/science.320.5884.1710. No abstract available.

PMID:
18583588
18.

Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006.

Mutonga DM, Pimentel G, Muindi J, Nzioka C, Mutiso J, Klena JD, Morcos M, Ogaro T, Materu S, Tetteh C, Messonnier NE, Breiman RF, Feikin DR.

Am J Trop Med Hyg. 2009 Apr;80(4):619-24.

PMID:
19346388
19.

Lack of antigenic diversification of major outer membrane proteins during clonal waves of Neisseria meningitidis serogroup A colonization and disease.

Huber CA, Pflüger V, Hamid AW, Forgor AA, Hodgson A, Sié A, Junghanss T, Pluschke G.

Pathog Dis. 2013 Feb;67(1):4-10. doi: 10.1111/2049-632X.12000. Epub 2012 Nov 28.

PMID:
23620114
20.

Emergence of W135 meningococcal meningitis in Ghana.

Forgor AA, Leimkugel J, Hodgson A, Bugri A, Dangy JP, Gagneux S, Smith T, Pluschke G.

Trop Med Int Health. 2005 Dec;10(12):1229-34.

Supplemental Content

Support Center